Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
9.55
-0.73 (-7.10%)
At close: Oct 30, 2026, 4:00 PM EDT
9.81
+0.26 (2.72%)
After-hours: Oct 30, 2026, 7:31 PM EDT
Adlai Nortye Group Market Cap
Adlai Nortye Group has a market cap or net worth of $615 million as of October 30, 2026. It is the 12,888th most valuable company in the world and the 2,590th biggest in the United States. Its market cap has increased by 1,011.10% in one year.
Market Cap
615.00M
Enterprise Value
408.88M
1-Year Change
1,011.10%
Global Rank
Country Rank
#2,590 United States
Category
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye Group's market cap has increased from $553.50M to $615.00M, an increase of 11.11%. That is a compound annual growth rate of 3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 615.00M | 1,073.70% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 637.40M |
| Aura Biosciences | 636.75M |
| Immix Biopharma | 636.69M |
| Iambic Therapeutics | 636.59M |
| Lexicon Pharmaceuticals | 631.84M |
| Aclaris Therapeutics | 615.29M |
| Olema Pharmaceuticals | 612.48M |
| Zevra Therapeutics | 610.47M |